Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

A Novel Revcar Platform for Switchable and Gated Tumor Targeting

Anja Feldmann, PhD, Anja Hoffmann, Enrico Kittel-Boselli, Ralf Bergmann, PhD, Stefanie Koristka, PhD, Nicole Berndt, PhD, Claudia Arndt, PhD, Liliana Raquel Loureiro, PhD, Nicola Mitwasi, Justyna Jureczek, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5611.

https://doi.org/10.1182/blood-2019-128436

Published: 2019

Journal Articles

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Anja Feldmann, PhD, Stefanie Koristka, PhD, Claudia Arndt, PhD, Liliana Raquel Loureiro, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Anja Hoffmann, Justyna Jureczek, Nicola Mitwasi, Martin Bornhaeuser, MD, Václav Hořejší, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5612.

https://doi.org/10.1182/blood-2019-128193

Published: 2019

Journal Articles

Development of Target Modules for Early and Late Stage Cancer Treatment Using Switchable Unicar T Cell Therapy

Liliana Raquel Loureiro, PhD, Anja Feldmann, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Stefanie Koristka, PhD, Nicola Mitwasi, Anja Hoffmann, Justyna Jureczek, Martin Bornhaeuser, MD, Michael Bachmann, MD, Claudia Arndt, PhD

Blood (2019) 134 (Supplement_1): 5613.

https://doi.org/10.1182/blood-2019-128249

Published: 2019

Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5614.

https://doi.org/10.1182/blood-2019-124279

Published: 2019

Journal Articles

Late-Stage Preclinical Characterization of Switchable CD123-Specific CAR-T for Treatment of Acute Leukemia

Simon Loff, MSc, Jan-Erik Meyer, Dipl. Biol., Josephine Dietrich, Msc, Johannes Spehr, PhD, Riewaldt Julia, PhD, Malte von Bonin, MD, Cordula Gründer, PhD, Kristin Franke, PhD, Anja Feldmann, PhD, Michael Bachmann, MD, Gerhard Ehninger, MD, Armin Ehninger, PhD, Marc Cartellieri, PhD

Blood (2018) 132 (Supplement 1): 964.

https://doi.org/10.1182/blood-2018-99-113288

Published: 2018

Journal Articles

Cytotoxic Activity Of Bispecific Antibody-Redirected Human Regulatory T Cells: Fact Or Artifact

Stefanie Koristka, M.Sc., Marc Cartellieri, PhD, Anja Feldmann, PhD, Claudia Arndt, M.Sc., Irene Michalk, M.Sc., Nicole Berndt, M.Sc., Martin Bornhäuser, MD, Gerhard Ehninger, MD, Michael Bachmann, PhD

Blood (2013) 122 (21): 5430.

https://doi.org/10.1182/blood.V122.21.5430.5430

Published: 2013

Journal Articles

Enhancing The Efficacy and Specificity Of Antibody-Based T Cell Retargeting Strategies Against Hematological Malignancies

Claudia Arndt, M.Sc., Marc Cartellieri, PhD, Roberta Aliperta, M.Sc., Stefanie Koristka, M.Sc., Irene Michalk, M.Sc., Martin Bornhäuser, MD, Gerhard Ehninger, MD, Michael Bachmann, PhD, Anja Feldmann, PhD

Blood (2013) 122 (21): 930.

https://doi.org/10.1182/blood.V122.21.930.930

Published: 2013

Journal Articles

The histone demethylase UTX regulates stem cell migration and hematopoiesis

Sebastian Thieme, Tobias Gyárfás, Cornelia Richter, Günes Özhan, Jun Fu, Dimitra Alexopoulou, Michael H. Muders, Irene Michalk, Christiane Jakob, Andreas Dahl, Barbara Klink, Joanna Bandoła, Michael Bachmann, Evelin Schröck, Frank Buchholz, A. Francis Stewart, Gilbert Weidinger, Konstantinos Anastassiadis, Sebastian Brenner

Blood (2013) 121 (13): 2462–2473.

https://doi.org/10.1182/blood-2012-08-452003

Published: 2013

Includes: Supplemental data

Journal Articles

Redirection of Immune Effector Cells by Bispecific Antibody Systems for the Treatment of Acute Myeloid Leukemia

Claudia Arndt, Anja Feldmann, Stefanie Koristka, Irene Michalk, Marc Cartellieri, Slava Stamova, Malte von Bonin, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Michael Bachmann

Blood (2011) 118 (21): 1528.

https://doi.org/10.1182/blood.V118.21.1528.1528

Published: 2011

Journal Articles

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia

Marc Cartellieri, Irene Michalk, Malte von Bonin, Thomas Krüger, Slava Stamova, Stefanie Koristka, Claudia Arndt, Anja Feldmann, Marc Schmitz, Martin Wermke, MD, Dirk Lindemann, Martin Bornhäuser, Gerhard Ehninger, MD, Michael Bachmann

Blood (2011) 118 (21): 2618.

https://doi.org/10.1182/blood.V118.21.2618.2618

Published: 2011

Journal Articles

Antigen-Specific Redirection of Human Regulatory T Cells by Bispecific Antibodies,

Stefanie Koristka, Marc Cartellieri, Anke Theil, Claudia Arndt, Anja Feldmann, Irene Michalk, Marc Schmitz, Karsten Kretschmer, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Michael Bachmann

Blood (2011) 118 (21): 4041.

https://doi.org/10.1182/blood.V118.21.4041.4041

Published: 2011

Journal Articles

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

Vu H. Nguyen, Sumana Shashidhar, Daisy S. Chang, Lena Ho, Neeraja Kambham, Michael Bachmann, Janice M. Brown, Robert S. Negrin

Blood (2008) 111 (2): 945–953.

https://doi.org/10.1182/blood-2007-07-103895

Published: 2008

Journal Articles

CD4+CD25+ Regulatory T Cells Enhance Immune Reconstitution Following Allogeneic Hematopoietic Cell Transplantation by Protecting Thymic and Lymphoid Compartments from Graft-Versus-Host Disease Damage without Impacting T Cell Repertoire Development.

Vu H. Nguyen, MD, Daisy Chang, BA, Sumana Shashidhar, BA, Michael Bachmann, PhD, Christopher H. Contag, PhD, Janice M.Y. Brown, MD, Robert S. Negrin, MD

Blood (2006) 108 (11): 70.

https://doi.org/10.1182/blood.V108.11.70.70

Published: 2006

NARROW

A Novel Revcar Platform for Switchable and Gated Tumor Targeting

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Development of Target Modules for Early and Late Stage Cancer Treatment Using Switchable Unicar T Cell Therapy

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Late-Stage Preclinical Characterization of Switchable CD123-Specific CAR-T for Treatment of Acute Leukemia

Cytotoxic Activity Of Bispecific Antibody-Redirected Human Regulatory T Cells: Fact Or Artifact

Enhancing The Efficacy and Specificity Of Antibody-Based T Cell Retargeting Strategies Against Hematological Malignancies

The histone demethylase UTX regulates stem cell migration and hematopoiesis

Redirection of Immune Effector Cells by Bispecific Antibody Systems for the Treatment of Acute Myeloid Leukemia

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia

Antigen-Specific Redirection of Human Regulatory T Cells by Bispecific Antibodies,

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

CD4+CD25+ Regulatory T Cells Enhance Immune Reconstitution Following Allogeneic Hematopoietic Cell Transplantation by Protecting Thymic and Lymphoid Compartments from Graft-Versus-Host Disease Damage without Impacting T Cell Repertoire Development.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only